These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30059371)

  • 1. A 20-Year-Old-Trauma Patient With Suspected Malignant Hyperthermia Following Induction With Succinylcholine: A Case Study.
    Luckey-Smith K; High K
    Adv Emerg Nurs J; 2018; 40(3):171-175. PubMed ID: 30059371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
    Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
    Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
    Flick RP; Gleich SJ; Herr MM; Wedel DJ
    Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
    Helf D; Schneiderbanger D; Markus CK; Johannsen S; Schuster F
    Anaesthesist; 2018 Apr; 67(4):275-279. PubMed ID: 29480319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
    Garrido S; Fraga M; Martín MJ; Belda J
    Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
    [No Abstract]   [Full Text] [Related]  

  • 11. Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum.
    Natasa N; Snezana P; Nemanja Z; Zoran K; Durasić L
    Acta Chir Iugosl; 2012; 59(2):121-3. PubMed ID: 23373371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study).
    Pulnitiporn A; Charuluxananan S; Inphum P; Kitsampanwong W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 7():S149-52. PubMed ID: 16862689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
    Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
    Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An attack of malignant hyperthermia caused by a combination of the effects of succinylcholine, increased physical exertion and alcohol abuse].
    Husová L; Lata J; Husa P
    Vnitr Lek; 1999 Dec; 45(12):716-9. PubMed ID: 10951847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of a prepared and ready malignant hyperthermia response team.
    Rosen GP; Escobar M; Fumero P; Viswanath O; Wright J
    J Clin Anesth; 2019 Sep; 56():109-110. PubMed ID: 30743151
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual case of malignant hyperthermia presenting on the acute medical take.
    Jones R; Shahid F; Cowell RP
    Br J Hosp Med (Lond); 2015 Feb; 76(2):110-1. PubMed ID: 25671478
    [No Abstract]   [Full Text] [Related]  

  • 17. Suxamethonium, masseter spasm and later malignant hyperthermia.
    Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
    Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia].
    Schuster F; Johannsen S; Roewer N
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Mar; 48(3):162-4. PubMed ID: 23592246
    [No Abstract]   [Full Text] [Related]  

  • 19. [ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine].
    HNO; 1995 Nov; 43(11):640-1. PubMed ID: 8530309
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.